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The  term  “biomarker”  can  refer  to  any  entity  that  occurs  in 
the body and can be measured to predict the diagnosis, onset or 
progression of a disease process. The definition of a biomarker is 
intentionally broad. It can apply to the assessment of specific genes, 
proteins, products of cellular processes, a series of biological processes 
or even the response of cells or tissues to therapeutic strategies. 
In fact, some biomarkers may have the additional benefit to func-
tion as a surrogate marker to be able to be used to predict clinical 
outcome in some cases. For example, biomarkers such as estrogen 
levels may predict the onset of postmenopausal breast cancer and 
a poor clinical outcome. Yet, reliance on any single biomarker can 
become  an  imperfect  science,  since  a  number  of  other  pathways 
that occur in combination with a particular biomarker may have a 
significant role. In the case of breast cancer, new work suggests that 
the release of androgens, cytokines or even changes in body mass 
and exercise can influence outcome as well as alter the predictability 
of a specific biomarker. For these reasons, assessment of multiple 
biomarkers may have greater clinical utility for the formulation of 
a diagnosis and the process of following disease outcome and thera-
peutic options.
In this regard, biomarkers have a critical utility in multiple disease 
processes especially those impacted by oxidative stress. In this issue 
of Oxidative Medicine and Cellular Longevity, our articles highlight 
some of the potential novel biomarkers to be considered in a variety 
of disorders and how these genes or proteins may ultimately alter 
oxidative stress and disease outcome. During both normal physi-
ological conditions and cellular stress, microparticles that consist of 
cell fragments can be released and may be indicative of tissue injury. 
Vince et al. show that vascular adhesion molecule-1 (VCAM-1) posi-
tive microparticle and S100A12, a calcium binding protein belonging 
to  the  S100  family,  may  function  as  biomarkers  for  endothelial 
dysfunction and neutrophil activity during oxidative stress. These 
proteins may provide important targets for early hypoxic injury since 
they become elevated following hypoxia in individuals. Interestingly, 
the effects of enhanced oxygen levels on endothelial cells also may 
stimulate different pathways that can serve as biomarkers but also 
alter vascular function. In their paper, Xu et. al. demonstrate that 
endothelial nitric oxide synthase (eNOS) mRNA and protein can 
become up-regulated in endothelial cells during hyperbaric oxygen 
exposure. However, this can be a delayed response that may or may 
not alter vascular tone but may function as a signal for other vascular 
pathways that have a role during disorders such as epilepsy. In disor-
ders such as thrombophilia, it appears that reactive oxygen species 
consisting of hydrogen peroxide are involved and that the generation 
of hydrogen peroxide sets into play the activation of an antioxidant 
defense system. The authors of this study, Pristiv et al., suggest that 
screening of the level of ascorbyl radical, which may be used to deter-
mine the oxidative status of amniotic fluid during pregnancy, could 
become an early biomarker for diseases such as thrombophilia.
Also in this issue of Oxidative Medicine and Cellular Longevity, 
novel  studies  illustrate  potential  therapeutic  strategies  directed 
against oxidative stress cellular injury. Bloomer and Fisher-Wellman 
link diets with high fat content to the release of excess free radicals 
in the body. Elevated free radical release in the body has been tied to 
a number of disorders such as heart disease, diabetes and Alzheimer’s 
disease. The study, which was confined to women, demonstrated 
that women who were obese were more likely to have higher and 
prolonged release of free radicals in the body when compared to 
non-obese counterparts. These findings shed significant light on the 
almost immediate role diet can play in relation to the development 
of long-term disorders in the body and provide vital information to 
design therapies for a number of diseases caused by oxidative stress. 
Work by Yanagida et al. identify a unique role for the astrocytic 
protein  DJ-1  during  oxidative  stress  and  illustrate  through  gene 
silencing studies and magnetic resonance imaging the neuroprotec-
tive capacity of DJ-1 when released from non-neuronal astrocytic 
cells. Other work by Helal et al. suggest that metallothionein induc-
tion by ZnSO4 can possibly preserve memory function through the 
prevention of hippocampal neuronal cell loss in the brain and reduce 
markers of oxidative stress during administration of the chemotherapy 
agent carmustine that results in learning and memory impairment. 
These original studies complement the review articles in this issue 
by  Fisher-Wellman  et  al.  that  discusses  the  potential  antioxidant 
pathways associated with exercise during cardiac and metabolic disor-
ders as well as the work by Kovacic and Somanathan that outlines 
unique pathways tied to memory formation during administration 
of the hypnotic Zolpiderm. For this issue of Oxidative Medicine and 
Cellular Longevity, we offer exciting new insights for our readers in 
regards to biomarkers and treatment strategies that affect multiple 
disease pathways, and more importantly, clinical outcome.
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